Companies
- Companies
- Company details
SUGEN
Summary
SUGEN is a biotechnology company developing drugs to target the regulation of signal transduction pathways within the body's cells.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 83 pages - $1,000
Sep 2011 - 40 pages - $1,000
Mar 2011 - 22 pages - $250
Feb 2011 - 35 pages - $125
Feb 2011 - 30 pages - $125
May 2011 - 34 pages - $125
May 2011 - 33 pages - $125
Nov 2010 - 46 pages - $2,500
Jan 2010 - $975
Jan 2011 - 127 pages - $2,350
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Pharmaceutical / Prescription
- Therapeutic target
- Gastrointestinal
- Musculoskeletal
- Oncology
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us